Month: May 2024

OR YEHUDA, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (“the Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, announced today its financial results for the first quarter ended March 31, 2024. Summary Results for the First Quarter 2024 (USD in millions, except per share data)             GAAP     Non-GAAP    Q1 2024 Q1 2023 % Change   Q1 2024 Q1 2023 % ChangeRevenues $ 130.7 $ 142.4 (8.2%)   $ 130.7 $ 142.4 (8.2%)Gross profit $ 36.7 $ 38.9 (5.6%)   $ 38.3 $ 40.1 (4.5%)Gross margin   28.1%   27.3% 80 bps     29.3%   28.2% 110 bpsOperating income $ 14.4 $ 15.3 (6.0%)   $ 18.1 $ 18.5 (1.7%)Operating margin   11.0%   10.8% 20 bps     13.9%   13.0% 90 bpsNet income (*) $ 8.8 $ 10.1 (13.0%)   $ 11.3 $ 12.6 (10.4%)Diluted...

Continued capital allocation discipline, interest rate risk fully hedged, sustainable quarterly dividend of $0.375 per common share, well-positioned for counter-cyclical opportunities, CEO transition successful & Chief Compliance Officer appointed ATHENS, May 16, 2024 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship Lease” or “GSL”), an owner of containerships, announced today its unaudited results for the three months ended March 31, 2024. First Quarter of 2024 Highlights – Reported operating revenue of $179.6 million for the first quarter of 2024, an increase of 12.7% on operating revenue of $159.3 million for the prior year period. – Reported net income available to common shareholders of $89.5 million for the first quarter of 2024, an increase of 24.0% on net income of $72.2...

Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer Therapeutic Platform Technology and Akari’s PAS-nomacopan for Geographic Atrophy Implementation of Restructuring Plan to Reduce Operating Costs Existing Investors Support the Company with Issuance of $1 million in Unsecured Convertible Notes BOSTON and LONDON, May 16, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the first quarter ended March 31, 2024 as well as recent company highlights.  “My first few weeks as Interim CEO of Akari have been filled with non-stop activity and...

NAPLES, Fla., May 16, 2024 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB: HLYK), a leading provider of healthcare networking and technological innovation, has reported its financial results for the first quarter ending March 31, 2024. Demonstrating significant progress in streamlining its operating structure, HealthLynked achieved an 8% increase in revenue compared to the fourth quarter of 2023, showcasing consistent quarter-over-quarter growth and efficiency. First Quarter 2024 Financial Highlights: Revenue: Despite a 43% year-over-year decline due to changes in clinical staffing (one physician retired, another due to illness, and the third moved out of the area), HealthLynked’s revenue reached $1.00 million for the first quarter. The 8% quarter-over-quarter increase underscores the company’s resilience...

Twelve-month primary analysis results by independent central review from the IGNYTE clinical trial of RP1 (vusolimogene oderparepvec) in anti-PD1 failed melanoma expected Q2 2024Recent Type C CMC meeting with the U.S. Food and Drug Administration (FDA) supports IGNYTE Biologics License Application (BLA) submission expected in 2H 2024Enrollment of first patients in Phase 3 confirmatory trial of RP1 in advanced melanoma expected in 2H 2024Cash runway to fund operations into 2H 2026WOBURN, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced financial results for the fiscal fourth quarter and year ended March 31, 2024 and provided a business update. “We have exciting milestones...

Reports First Quarter Financial Results for Fintech Operations DALLAS, May 16, 2024 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced that it filed its Form S-4 on May 13, 2024, for its acquisition of Evtec Aluminium Ltd. and today reported its financial results for the first quarter ended March 31, 2024. The filing of the S-4 was a significant milestone in the Company’s planned acquisition of Evtec Aluminium Ltd. Pending SEC and Nasdaq approval, the Company expects to consummate the merger as soon as possible. First Quarter Financial and Operating Highlights:Total revenue for the first quarter of 2024 was $649,420 as compared to $859,004 for...